Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 138, Issue 3, Pages 491-499
Publisher
Springer Nature
Online
2011-12-22
DOI
10.1007/s00432-011-1127-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
- (2011) J B Baker et al. BRITISH JOURNAL OF CANCER
- Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment
- (2011) I. Tinhofer et al. CLINICAL CANCER RESEARCH
- Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors
- (2010) Myung Hee Chang et al. CANCER
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Coomassie Staining as Loading Control in Western Blot Analysis
- (2010) Charlotte Welinder et al. JOURNAL OF PROTEOME RESEARCH
- Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
- (2010) Hiromitsu Hatakeyama et al. PLoS One
- Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab
- (2009) Bart Jacobs et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
- (2009) Eva Henriksson et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
- (2009) G. Niu et al. JOURNAL OF NUCLEAR MEDICINE
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
- (2009) Ann Marie Egloff et al. Journal of Oncology
- Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers
- (2008) K. Yonesaka et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines
- (2008) Takashi Yamatodani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More